The EVICEL® Gastrointestinal Study

NCT01589822 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
214
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ethicon, Inc.